Skip to main content
SpringerLink
Log in

Gastric mucosal protection by new aryl sulfhydryl drugs

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Alkyl sulfhydryl drugs protect against acute gastric hemorrhagic mucosal lesions. We tested the protective effect of cyclic drugs containing oxidized (KT1-32, KT1-39, KT1-94), or reduced (KT1-66, KT1-109, KT1-293, KT1-720, KT1-756) sulfhydryls. The most potent protective agents (KT1-32, KT1-109, KT1-720, KT1-756) were investigated in detail. Drugs were administered intragastrically to fasted rats 30 min before 100% ethanol (1 ml) or acidified aspirin (10 mg/100 g), and mucosal lesions were measured planimetrically 1 hr later. Control rats receiving only ethanol had lesions involving 14.5% of the glandular mucosa. KT1-32, KT1-109, KT1-720, or KT1-756 (10 mg/100 g) reduced lesions to 0.7, 2.7, 1.8, or 0.7% of glandular stomach respectively. Aspirin-induced lesions involved 1.52% of the glandular mucosa and 10 mg/100 g of KT1-32, KT1-109, or KT1-720, or 2 mg/100 g of KT1-756 diminished the damage to 0.13, 0.02, or 0.04, or 0.00%, respectively. Indomethacin interfered with protection against ethanol by KT1-109, while the sulfhydryl alkylator N-ethylmaleimide abolished protection by both KT1-32 and KT1-109. Among the drugs investigated in detail, KT1-756 increased gastric acid output, while KT1-720 and KT1-756 significantly enhanced pepsin secretion. All four compounds studied in detail (ie, KT1-32, KT1-109, KT1-720, KT1-756) decreased the extent of vascular lesions in the gastric mucosa as revealed by monastral blue 1 min after ethanol. Thus, the mechanism of gastric mucosal protection by these novel aryl sulfhydryl compounds cannot be ascribed to an antisecretory effect, but may be related to prevention of vascular injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Morson BC, Dawson IMP: Gastrointestinal Pathology. Oxford, Blackwell Scientific, 1972, p 80

    Google Scholar 

  2. Lev R, Kawashima K, Glass GB: Morphologic features and healing of stress ulcers induced by alcohol and restraint. Arch Pathol Lab Med 100:554–558, 1976

    PubMed  Google Scholar 

  3. Hingson DJ, Ito S: Effect of aspirin and related compounds on the fine structure of mouse gastric mucosa. Gastroenterology 61:156–177, 1971

    PubMed  Google Scholar 

  4. Robert A: Cytoprotection by prostaglandins. Gastroenterology 77:761–767, 1979

    PubMed  Google Scholar 

  5. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433–443, 1979

    PubMed  Google Scholar 

  6. Szabo S, Trier JS, Frankel, PW: Sulfhydryl compounds may mediate gastric cytoprotection. Science 214:200–202, 1981

    PubMed  Google Scholar 

  7. Miller TA, Jacobson ED: Gastrointestinal cytoprotection by prostaglandins. Gut 20:75–87, 1979

    PubMed  Google Scholar 

  8. Kivilaakso E, Silen W: Pathogenesis of experimental gastricmucosal injury. N Engl J Med 301:364–369, 1979

    PubMed  Google Scholar 

  9. Grossman MI: Protection of gastric mucosa by prostaglandins. Gastroenterology 77:593–594, 1979

    PubMed  Google Scholar 

  10. Fromm D: Gastric mucosal “barrier.” Gastroenterology 77:396–398, 1979

    PubMed  Google Scholar 

  11. Lacy ER, Ito S: Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology 83:619–625, 1982

    PubMed  Google Scholar 

  12. Szabo S, Trier JS: Pathogenesis of acute mucosal injury: Sulfhydryls as a protector, adrenal cortex as a modulator, and vascular endothelium as a target.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 287–293

    Google Scholar 

  13. Szabo S, Trier JS, Brown A, Schnoor J: Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 88:228–236, 1985

    PubMed  Google Scholar 

  14. Guth PH, Paulsen G, Nagata H: Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: Effect of prostaglandin cytoprotection. Gastroenterology 87:1083–1090, 1984

    PubMed  Google Scholar 

  15. Szabo S, Brown A, Schnoor J, Homan HD, Bradford JC: A quantitative method for assessing the extent of experimental gastric erosions and ulcers. J Pharmacol Methods 13:59–66, 1985

    PubMed  Google Scholar 

  16. Szabo S, Trier JS, Brown A, Schnoor J: Sulfhydryl blockers induce severe inflammatory gastritis in the rat. Gastroenterology 86:1271, 1984

    Google Scholar 

  17. Gallagher GT, Szabo S: Secretory changes associated with chemically induced duodenal ulceration: Simultaneous measurements of acid, pepsin, base, and pancreatic enzymes in rats with chronic gastric fistula. Digestion 29:73–84, 1984

    PubMed  Google Scholar 

  18. Lacy ER, Ito S: Rapid epithelial restitution of the rat gastric mucosa after ethanol injury. Lab Invest 51:573–583, 1984

    PubMed  Google Scholar 

  19. Pihan G, Majzoubi D, Trier JS, Szabo S: Microcirculatory stasis and mucosal hypoperfusion in acute gastric mucosal injury in the rat: Prevention by a prostaglandin and thiosulfate. Gastroenterology 90:1586, 1986

    Google Scholar 

  20. Szabo S, Pihan G, Trier JS: Alterations in blood vessels during gastric injury and protection. Scand J Gastroenterol 21 (Suppl. 125):92–96, 1986

    Google Scholar 

  21. Davenport HW: The gastric mucosal barrier. Past, present, and future. Mayo Clin Proc 50:507–514, 1975

    PubMed  Google Scholar 

  22. Domschke S, Domschke W: Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 13:405–436, 1984

    PubMed  Google Scholar 

  23. Morris GP, Wallace JL, Harding PL: Effects of prostaglandin E2 on salicylate-induced damage to the rat gastric mucosa: Cytoprotection is not associated with preservation of the gastric mucosal barrier. Can J Physiol Pharmacol 62:1065–1069, 1984

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pathology, Brigham and Women's Hospital and Harvard Medical School, 02115, Boston, Massachusetts

    C. Rogers BA, A. Brown BS & S. Szabo MD

Authors
  1. C. Rogers BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Brown BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Szabo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rogers, C., Brown, A. & Szabo, S. Gastric mucosal protection by new aryl sulfhydryl drugs. Digest Dis Sci 33, 324–329 (1988). https://doi.org/10.1007/BF01535758

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01535758

Key words

Search

Navigation